Christine D. Baker
Director/Board Member at TuHURA Biopharma, Inc.
Net worth: 11 504 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James A. Bianco | M | 67 |
TuHURA Biopharma, Inc.
 TuHURA Biopharma, Inc. BiotechnologyHealth Technology TuHURA Biopharma, Inc. operates as a biotechnology company. It develops bifunctional immunoconjugates for the treatment of cancer. The company was founded in 2018 and is headquartered in Seattle,WA. | - |
| Roman Necina | M | 56 | 5 years | |
| Mary Coelho | F | 62 | 1 years | |
| Timothy Reilly | M | 50 | 2 years | |
| Malte Peters | M | 61 | 1 years |
See more
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James Biehl | M | 60 | 5 years | |
| Douglas Michels | M | 66 | 4 years | |
| Tim Tyson | M | 71 | 7 years | |
| Donald DeGolyer | M | 63 | 4 years | |
| Jean-Charles Soria | M | 53 | - | |
| Gerald H. Sokol | M | 81 | 8 years | |
| Richard Cunningham | M | 54 | 2 years | |
| Christoph S. Lengauer | M | 59 | 4 years | |
| Daniel D. Pinschewer | M | 49 | 8 years | |
| David P. Carberry | M | 71 | 5 years | |
| Graziano Seghezzi | M | 55 | 10 years | |
| Jonathan Eckard | M | 50 | 5 years | |
| Sander J. van Deventer | M | 69 | 9 years | |
| Anders Lilja | M | - | 7 years | |
| Michael Kelly | M | 67 | 4 years | |
| Katia Schlienger | M | 62 | 2 years | |
| Nina Waibel | F | - | 3 years | |
| Matthew Beck | M | - | 4 years | |
| Igor Matushansky | M | 51 | 5 years | |
| Gwenaelle Kerforn | F | - | 3 years | |
| Jan van Tornout | M | 68 | 1 years | |
| Frank L. Porfido | M | 60 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 27 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christine D. Baker
- Personal Network
